Home/Filings/4/0001104659-22-084893
4//SEC Filing

Piccina Cintia 4

Accession 0001104659-22-084893

CIK 0001621227other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 9:00 PM ET

Size

6.5 KB

Accession

0001104659-22-084893

Insider Transaction Report

Form 4
Period: 2022-08-01
Piccina Cintia
Chief Commercial Officer
Transactions
  • Sale

    American Depositary Shares representing Ordinary Shares

    2022-08-01$1.77/sh21,040$37,31434,824 total
Footnotes (3)
  • [F1]Each American Depositary Share ("ADS") represents six ordinary shares, nominal value GBP 0.001 per ordinary share, of the Issuer. The ADSs were obtained from the exercise of approximately 25% of an RSU-style share option covering ordinary shares of the Issuer granted on January 31, 2022 and which have vested. Once vested, the RSU-style options must be exercised within a restricted period or they are forfeited. The exercise of the portion of these RSU-style share options and the sale reported in this Form 4 were effected pursuant to a Sell to Cover exercise implemented automatically in accordance with the Issuer's option plan, under which sufficient ADSs were sold by the Issuer to satisfy the Reporting Person's tax withholding obligations and associated sale costs. The residual ADSs are held by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $1.7642 to $1.7808, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission with full information regarding the ADSs sold at this price in this footnote.
  • [F3]The ADSs reported in this Column 5 represent solely those residual ADSs held by the Reporting Person which result from the Sell to Cover exercise transaction reported on this Form 4. Additionally, the Reporting Person holds RSU-style options and other options covering an aggregate of 4,131,192 ordinary shares of the Issuer.

Issuer

Adaptimmune Therapeutics PLC

CIK 0001621227

Entity typeother

Related Parties

1
  • filerCIK 0001907199

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 9:00 PM ET
Size
6.5 KB